Operation Worth Living Project With Suicidal Soldiers at Ft. Stewart
This trial is active, not recruiting.
|Conditions||suicidal ideation active, suicidal and self-injurious behavior|
|Treatments||the collaborative assessment and management of suicidality, enhanced care as usual|
|Sponsor||The Catholic University of America|
|Collaborator||University of Washington|
|Start date||March 2011|
|End date||March 2017|
|Trial size||150 participants|
|Trial identifier||NCT01300169, 09134002, CUA-001|
This is a randomized controlled trial comparing the use of new clinical intervention (the "Collaborative Assessment and Management of Suicidality--CAMS") versus enhanced care as usual for suicidal Soldiers who are seen at outpatient mental health clinics at Ft. Stewart GA.
|Intervention model||single group assignment|
|Masking||double blind (subject, outcomes assessor)|
Scale for Suicidal Ideation
time frame: Baseline, post-treatment, 1, 3, 6, 12 months
Overall symptom distress
time frame: Baseline, post treatment, 1, 3, 6, 12 months
Male or female participants from 18 years up to 65 years old.
Inclusion Criteria: - Active duty Army personnel at FSGA - Significant suicidal ideation - Soldier is appropriate under FSGA policies - Consent at baseline and follow up - Consent to randomization and being digitally recorded Exclusion Criteria: - Significant psychosis, cognitive or physical impairment to not give consent - Judicially ordered treatments
|Official title||A Randomized Clinical Trial of the Collaborative Assessment and Management of Suicidality Versus Enhanced Care as Usual for Suicidal Soldiers|
|Principal investigator||David A. Jobes, Ph.D.|
|Description||This is a randomized controlled clinical trial of 148 suicidal active-duty US Army Soldiers. Participants were randomized to on-site providers who were trained in the Collaborative Assessment and Management of Suicidality (CAMS) vs. providers doing their own routine care--referred to as Enhanced Care as Usual (E-CAU) within an outpatient military treatment center. The CAMS Rating Scale (CRS) was used to reliably verify fidelity between treatment conditions and the adherence by CAMS providers to the model. Participants received informed consent to be randomly assigned to treatment arm and were ask to complete study assessments at baseline, 3 months, 6 months, and 12 months after the start of treatment. Recruitment is complete and all study assessments were completed as of March 2016. The study is in a second year of no cost extension; outcome data analyses and moderator analyses are currently underway to develop manuscripts for submission to peer-review scientific journals.|
Call for more information